Step 1: Understanding the Concept:
Most diuretics must be present within the renal tubular lumen to interact with transport proteins located on the luminal membrane of renal epithelial cells.
However, drugs acting on intracellular receptors or from the basolateral membrane do not require luminal entry.
Detailed Explanation:
Let us analyze the site of action for each class of diuretics:
- Loop diuretics (e.g., furosemide) must be secreted into the tubular lumen to block the $Na^+/K^+/2Cl^-$ cotransporter (NKCC2) on the luminal membrane of the thick ascending limb of Henle.
- Thiazide diuretics (e.g., hydrochlorothiazide) act from the luminal side to inhibit the $Na^+/Cl^-$ cotransporter (NCC) in the distal convoluted tubule.
- Carbonic anhydrase inhibitors (e.g., acetazolamide) must enter the lumen to inhibit luminal carbonic anhydrase enzymes in the proximal convoluted tubule.
- Aldosterone antagonists (e.g., spironolactone) are highly lipophilic molecules.
They cross the basolateral membrane from the bloodstream and bind to intracellular mineralocorticoid receptors located in the cytoplasm of principal cells in the late distal tubule and collecting duct.
By blocking these intracellular receptors, they prevent the synthesis of aldosterone-induced proteins (AIPs) without needing to enter the tubular fluid.
Step 2: Final Answer:
Aldosterone antagonists do not require their presence in the renal tubular lumen to exert their pharmacological effects.